$Scynexis (SCYX.US)$Reuters· 2 mins ago Scynexis Initiates Dosing in Phase 1 Trial of Scy-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections
Trytosaveabit
OP
芳晴
:
Sorry for late reply! Fridays I have to leave trading around 9:30AM! But yes it had just like no volume today! It will continue down or at least trade sideways until something happens to bring volume. Again apologies for late response. Hope you have a good weekend
$RIOT 250117 20.00C$when banks start to slow down due to holidays, Riot and BTC will skyrocket as Crypto will be open when banks close... Buy calls 01/17 📈🚀
Rhiox
Marquezs
OP
:
ok, just curious because it doesn't seem to have anything to do with IMPP. not use to seeing random thoughts in comments. thanks for explaining.
$Scynexis (SCYX.US)$Reuters· just Scynexis to Receive $10 Million Milestone Payment From GSK Triggered by Delivery of Completed Furi, Cares and Nature Clinical Study Reports
2
1
Report
Trytosaveabit
OP
:
Scynexis : GSK Will Also Pay Mid-Single Digit to Mid-Teen Digit Tiered Royalties on Totality of Ibrexafungerp Sales Across All Indications
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Scynexis Stock Forum
Waiting for at least 1.09
Scynexis Initiates Dosing in Phase 1 Trial of Scy-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections
loading...
Scynexis to Receive $10 Million Milestone Payment From GSK Triggered by Delivery of Completed Furi, Cares and Nature Clinical Study Reports
No comment yet